SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E
http://www.w3.org/2000/01/rdf-schema#comment
"Expression of 6PGD positively correlates with advancing stage of lung carcinoma. Knockdown of 6PGD by shRNA potently inhibits c-Met tyrosine phosphorylation."
xsd:string
http://purl.uniprot.org/uniprot/#_B4EF3E2A4932D497251FED239A731095BEE001FF0DEFB22DA90DD75ED578B276774EF22D01CB0ED19BDF53BB74A565CF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E
http://purl.uniprot.org/uniprot/B4DV68
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E
http://purl.uniprot.org/uniprot/#_B4DV68-mappedCitation-23973484
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E7A0B0E40A7F19CD6B6C3D842BEA32EE050B1A65DD40C8E8B443FC9BB5D076769222A4A7D7CBF525094CD6EDA9CF544E